Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy

NCT02897921 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT02897921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02897921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2016
Completion date
August 31, 2021
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recessive gene myopathies